Rezension:

I read a lot http://blog.cilek.com/etiket/2018/ super p force wikipedia The FDA granted priority review designation to a marketing application seeking approval of Bayer and Onyx Pharmaceuticals' Nexavar (sorafenib) for the treatment of locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer, the companies said Tuesday. The agency is scheduled to make a decision on the submission by December 25.

Bewertung: